Benzinga | Nov 5, 2021 09:28AM EDT

Novavax Q3 EPS $(4.31) Misses $(3.91) Estimate, Sales $178.84M Miss $334.62M Estimate

Novavax (NASDAQ:NVAX) reported quarterly losses of $(4.31) per share which missed the analyst consensus estimate of $(3.91) by 10.23 percent. This is a 34.27 percent decrease over losses of $(3.21) per share from the same period last year. The company reported quarterly sales of $178.84 million which missed the analyst consensus estimate of $334.62 million by 46.55 percent. This is a 13.90 percent increase over sales of $157.02 million the same period last year.